ArticleCancer gene therapy2024

Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway.

Wei-Feng Xia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.